Combined analysis of estrogen receptor beta-1 and progesterone receptor expression identifies lung cancer patients with poor outcome. - Wikidata - wikimedia - TriplyDB

Combined analysis of estrogen receptor beta-1 and progesterone receptor expression identifies lung cancer patients with poor outcome.

Combined analysis of estrogen receptor beta-1 and progesterone receptor expression identifies lung cancer patients with poor outcome.

http://www.wikidata.org/entity/Q34719991

about

Sex-specific lung diseases: effect of oestrogen on cultured cells and in animal models Estrogen signaling in lung cancer: an opportunity for novel therapy Circulating microRNAs in relation to EGFR status and survival of lung adenocarcinoma in female non-smokers Targeting the estrogen pathway for the treatment and prevention of lung cancer The role of estrogen, progesterone and aromatase in human non-small-cell lung cancer Lung cancer in women Exploring estrogenic activity in lung cancer Progesterone receptor (PR) polyproline domain (PPD) mediates inhibition of epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer cells.Modeling the overall survival of patients with advanced-stage non-small cell lung cancer using data of routine laboratory tests.Correlation between epidermal growth factor receptor mutations and the expression of estrogen receptor-β in advanced non-small cell lung cancer Minireview: Familiar Faces in Unfamiliar Places: The Emerging Role of Nuclear Receptors in Lung Cancer ERβ-mediated estradiol enhances epithelial mesenchymal transition of lung adenocarcinoma through increasing transcription of midkine.Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer Survival in women with NSCLC: the role of reproductive history and hormone use.Estrogen receptor 1 gene expression and its combination with estrogen receptor 2 or aromatase expression predicts survival in non-small cell lung cancer.Significance of the progesterone receptor and epidermal growth factor receptor, but not the estrogen receptor, in chemically induced lung carcinogenesis in female A/J mice.Estrogen receptors as the novel therapeutic biomarker in non-small cell lung cancer.Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer Ligand-dependent differences in estrogen receptor beta-interacting proteins identified in lung adenocarcinoma cells corresponds to estrogenic responses.Combining the multitargeted tyrosine kinase inhibitor vandetanib with the antiestrogen fulvestrant enhances its antitumor effect in non-small cell lung cancer Overexpression of estrogen receptor beta is a prognostic marker in non-small cell lung cancer: a meta-analysis NF-κB1 p105 suppresses lung tumorigenesis through the Tpl2 kinase but independently of its NF-κB function.Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome.Nuclear estrogen receptor-α expression is an independent predictor of recurrence in male patients with pT1aN0 lung adenocarcinomas, and correlates with regulatory T-cell infiltration Prognostic significance of aromatase and estrogen receptor beta expression in EGFR wild-type lung adenocarcinoma Prevention of tobacco carcinogen-induced lung cancer in female mice using antiestrogens.Steroid sulphatase and oestrogen sulphotransferase in human non-small-cell lung carcinoma Reduced Ets Domain-containing Protein Elk1 Promotes Pulmonary Fibrosis via Increased Integrin αvβ6 Expression Prognostic value of the expression of estrogen receptor β in patients with non-small cell lung cancer: a meta-analysis Regulation of submaxillary gland androgen-regulated protein 3A via estrogen receptor 2 in radioresistant head and neck squamous cell carcinoma cells.Smoking out reproductive hormone actions in lung cancer.Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex Estrongenic steroid hormones in lung cancer.Estrogen receptor-β in mitochondria: implications for mitochondrial bioenergetics and tumorigenesis.Exon 7 splicing variant of estrogen receptor α is associated with pathological invasiveness in smoking-independent lung adenocarcinoma.Cytoplasmic estrogen receptor β as a potential marker in human non-small cell lung carcinoma.Inhibition of non-small-cell lung cancer growth by combined fulvestrant and vandetanib.Estrogen promotes tumor metastasis via estrogen receptor beta-mediated regulation of matrix-metalloproteinase-2 in non-small cell lung cancer.Estrogen, Estrogen Receptor and Lung Cancer Estrogen and insulin-like growth factor 1 synergistically promote the development of lung adenocarcinoma in mice.

P2860

Q27687650-10704EB1-8EE5-4275-A755-25AD7705C5BD Q28385714-B4C9B5DF-F37D-4AC1-A436-733E96BF0103 Q28391728-CCB1836C-2DF2-4895-80D2-2F4250ADD4FE Q28397456-F5F607CE-D618-45C1-A107-BB26E3F2696E Q28397662-E3F397D4-47DD-4199-94E0-CDCC67081FBC Q29248783-626E580E-4D73-430D-AA10-1DDFF38ACD3F Q29248785-562BD24E-473D-47BC-B14E-0E4CDA6BBB92 Q30009019-C67E3BC5-DE65-4E34-BBEE-C3E2C99D879E Q30827122-2639E92D-F80F-441C-AD28-87A3EBB239CF Q33598556-17C1AA48-2640-4740-A2A6-FBC8708607DD Q33631471-847B9DE4-7F65-42A1-A238-38D88D8E90B6 Q33636340-698188D5-1819-4B5D-A796-7CAA8F854967 Q33648356-2D5EE915-7108-4F4F-BFAF-DBE0AE0790CA Q34235471-6BD95655-4B90-43E4-BFD3-EDBEC8BC219D Q34332088-65DB6506-8DA6-4241-BB0B-14F106CA44B7 Q34427354-7A8B3E7D-3765-4ED3-90FF-2C55B291E4A3 Q34657570-00696E07-2BA8-4A89-AD44-1A7047E10A3B Q35085764-58F2EDD6-66B1-484F-812A-A5B302113316 Q35338975-BD43B4C3-827F-4889-A317-E7C56D971209 Q35784523-206EC558-B4F9-41C8-8F63-5FAC3C3AE18F Q35958787-CB060D16-205D-4D22-A7FC-D96B639DC69A Q35994472-1164CAA7-A722-4514-B57B-091927A6EB51 Q36378853-D256E5C7-1059-4405-BA49-35CCF7B33732 Q36413817-501856BD-7F2B-4996-93EA-2585507D8476 Q36595093-C378F94A-7E68-49F4-B05C-DF5F45913B44 Q36646986-6241F1A0-3B93-4B91-814F-371FE3958C1F Q36775374-B3B450C8-C041-412D-9D91-F08433469D08 Q36850011-8DA71ECA-4B87-4025-926D-613185217169 Q36874786-3C36E921-7522-4A32-B950-75E464425F38 Q37628053-992E02CB-1853-4BAA-B468-45D922CC425B Q37679479-B4A39165-7F6E-41A1-953C-BB4F4191B1C9 Q37696192-6B54913D-1828-4762-A07B-1CDF0747AACE Q37726987-E91D84E6-CE83-4420-A46E-7863378A1E0B Q38572516-81166F33-BCCA-4BD3-B1E5-40F569A91AD6 Q38686007-24F7E5E6-2C8E-46D0-BBCF-9D0C8F28E973 Q39400232-A83A6BD9-57AD-40B6-AE00-11C53DD0BBAA Q39610522-C94F8453-FFEF-49A5-B037-0B6C7DD432F0 Q41346308-79C2CFDE-9814-4EFE-B837-031715C262EB Q41573792-B3C6FADD-E900-4B4D-A9BD-D697434C24F2 Q46746225-318B6A71-6F3D-45D9-AA0E-C577DEDA75BE

P2860

Combined analysis of estrogen receptor beta-1 and progesterone receptor expression identifies lung cancer patients with poor outcome.

http://www.wikidata.org/entity/Q34719991

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Combined analysis of estrogen ...... er patients with poor outcome.

@ast

Combined analysis of estrogen ...... er patients with poor outcome.

@en

Combined analysis of estrogen ...... er patients with poor outcome.

@nl

type

label

Combined analysis of estrogen ...... er patients with poor outcome.

@ast

Combined analysis of estrogen ...... er patients with poor outcome.

@en

Combined analysis of estrogen ...... er patients with poor outcome.

@nl

prefLabel

Combined analysis of estrogen ...... er patients with poor outcome.

@ast

Combined analysis of estrogen ...... er patients with poor outcome.

@en

Combined analysis of estrogen ...... er patients with poor outcome.

@nl

P1433

Q34719991-9F5EB955-E417-4C45-8FF3-5E9CD4CFA3B0

P1476

Q34719991-8A5BFB56-5119-4D95-B3E9-7581B3E7FA7E

P2093

Q34719991-37733F1C-DD56-47E8-825A-82A30EE0A98A

Q34719991-56299A92-389D-4085-8A3E-35700605ED32

Q34719991-5F0BBE0F-BA43-4C29-9E78-A0ED4400BB0A

Q34719991-73E08E17-9BFC-4008-B11B-7931D52F48F3

Q34719991-80D05BB3-1859-4A08-91FE-D77BD82FE954

Q34719991-A546353B-E2A7-475A-96AD-163E145B2605

Q34719991-AF1E2876-E22A-4277-9747-27C0D80F1A6D

Q34719991-C63AB315-5508-4C35-B58F-7BFB341AE59E

P2860

Q34719991-1CC88EAF-A1A0-4C33-934E-D49BE4EAD29F

Q34719991-202CF70D-5CAD-4ACD-9425-3EEBE5B1585E

Q34719991-2E7EB937-40DF-4D65-9396-4BA23D431A58

Q34719991-34E2E4C1-E8D6-4669-A60E-6E040C14C120

Q34719991-386813E6-82A3-4BC1-8B6D-9C57AF8EE903

Q34719991-3B248E8F-31C9-462E-8C5F-DA1CD638F0E8

Q34719991-3FC08AF8-4465-492E-8E7D-D004CA4F56A3

Q34719991-4BA5EC41-782A-4788-BB88-CEC031AE5403

Q34719991-7FB63A23-C7F2-46CA-9D92-D139A7F32EE5

Q34719991-85ED0151-7E3E-46CB-8BBC-F1BB13B777E5

P304

Q34719991-DA1CC913-11DA-4F4E-8D05-113EE95CEC30

P31

Q34719991-456B879A-8854-42C9-83DD-FB2CF770C7D2

P356

Q34719991-4A8E8C18-4030-477C-8C9F-5B7248110AF7

P407

Q34719991-4FA1D21C-E578-44AE-BD99-4D0DD952A841

P433

Q34719991-35F723DC-1385-46F6-82EC-2D74C0AF32B1

P478

Q34719991-470A830F-D7BC-4380-80F1-F5DFE9E8DB06

P50

Q34719991-F53FFC77-E79E-4C8B-ADDA-3AB887B52A02

P577

Q34719991-66237288-97B9-4FE6-A6C5-DFB2CEF6493D

P698

Q34719991-30EAC729-1E6F-41A9-A3FE-E8B55388B853

P921

Q34719991-20B0FB4C-70F4-4670-A6BE-5BD8FF5CC742

P932

Q34719991-EF9187AB-2EF4-40AB-93BC-A2E3DCC8FE11

P356

1078-0432.CCR-10-0992

P1433

Clinical Cancer Research

P1476

Combined analysis of estrogen ...... er patients with poor outcome.

@en

P2093

Diana E Lenzner

http://www.w3.org/2001/XMLSchema#string

Jill M Siegfried

http://www.w3.org/2001/XMLSchema#string

Laura P Stabile

http://www.w3.org/2001/XMLSchema#string

Marie Acquafondata

http://www.w3.org/2001/XMLSchema#string

Rajiv Dhir

http://www.w3.org/2001/XMLSchema#string

Rodney J Landreneau

http://www.w3.org/2001/XMLSchema#string

Sanja Dacic

http://www.w3.org/2001/XMLSchema#string

Stephanie R Land

http://www.w3.org/2001/XMLSchema#string

P2860

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Lung cancer and hormone replacement therapy: association in the vitamins and lifestyle study

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation.

Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial.

Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells.

Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome.

Survival impact of epidermal growth factor receptor overexpression in patients with non-small cell lung cancer: a meta-analysis.

Aromatase expression predicts survival in women with early-stage non small cell lung cancer.

Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells.

P304

154-164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-10-0992

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Jennifer Grandis

P577

2010-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21062926

http://www.w3.org/2001/XMLSchema#string

P921

P932

3064257

http://www.w3.org/2001/XMLSchema#string